Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2025-12-29 @ 5:56 PM
Study NCT ID:
NCT00437268
Status:
COMPLETED
Last Update Posted:
2020-07-21
First Post:
2007-02-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-05
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-16
First Submit QC Date:
None
Study First Post Date:
2007-02-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-09
Results First Submit QC Date:
None
Results First Post Date:
2020-07-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-04-20
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-07-20
Last Update Post Date:
2020-07-21
Last Update Post Date Type:
ACTUAL